Artykuły udostępnione publicznie: - Leandro CastellanoWięcej informacji
Niedostępne w żadnym miejscu: 12
miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells
M Maftouh, A Avan, N Funel, AE Frampton, H Fiuji, S Pelliccioni, ...
Nucleosides, Nucleotides and Nucleic Acids 33 (4-6), 384-393, 2014
Upoważnienia: Government of Italy
The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis
J Krell, AE Frampton, J Jacob, L Pellegrino, L Roca-Alonso, D Zeloof, ...
Molecular diagnosis & therapy 16, 167-172, 2012
Upoważnienia: Cancer Research UK
LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5
J Jacob, R Favicchio, N Karimian, M Mehrabi, V Harding, L Castellano, ...
Cancer letters 372 (1), 137-146, 2016
Upoważnienia: Cancer Research UK, UK Medical Research Council, National Institute for …
The p53 miRNA interactome and its potential role in the cancer clinic
J Krell, AE Frampton, T Colombo, TMH Gall, A De Giorgio, V Harding, ...
Epigenomics 5 (4), 417-428, 2013
Upoważnienia: Cancer Research UK, UK Medical Research Council
Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and disease
P Cathcart, W Lucchesi, S Ottaviani, A De Giorgio, J Krell, J Stebbing, ...
Best Practice & Research Clinical Endocrinology & Metabolism 29 (4), 529-543, 2015
Upoważnienia: Cancer Research UK, UK Medical Research Council, National Institute for …
miRNAs in breast cancer: ready for real time?
J Krell, AE Frampton, J Jacob, L Castellano, J Stebbing
Pharmacogenomics 13 (6), 709-719, 2012
Upoważnienia: Cancer Research UK
Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical use
AE Frampton, TMH Gall, E Giovannetti, J Stebbing, L Castellano, LR Jiao, ...
Expert review of molecular diagnostics 13 (4), 325-329, 2013
Upoważnienia: Cancer Research UK, UK Medical Research Council
miR-15b and miR-17 are tumor-derived plasma microRNAs dysregulated in colorectal neoplasia
AE Frampton, J Krell, TMH Gall, L Castellano, J Stebbing, LR Jiao
Annals of Surgery 262 (2), e61-e62, 2015
Upoważnienia: Cancer Research UK
Integrated analysis of miRNA and mRNA profiles enables target acquisition in human cancers
AE Frampton, J Krell, L Pellegrino, L Roca-Alonso, LR Jiao, J Stebbing, ...
Expert Review of Anticancer Therapy 12 (3), 323-330, 2012
Upoważnienia: Cancer Research UK
Retinoblastoma protein determines aggressiveness in triple-negative breast cancer
J Jacob, AE Frampton, L Castellano, J Stebbing, J Krell
Expert Review of Anticancer Therapy 12 (5), 581-584, 2012
Upoważnienia: Cancer Research UK
Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathways
AE Frampton, J Krell, E Giovannetti, D Krell, J Stebbing, L Castellano, ...
Expert Review of Anticancer Therapy 12 (10), 1275-1278, 2012
Upoważnienia: Cancer Research UK
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease
G Liu, AC Hsu, S Geirnaert, C Cong, PM Nair, S Shen, JE Marshall, ...
Molecular Therapy, 2025
Upoważnienia: National Health and Medical Research Council, Australia, Netherlands …
Dostępne w jakimś miejscu: 55
5′ isomiR variation is of functional and evolutionary importance
GC Tan, E Chan, A Molnar, R Sarkar, D Alexieva, IM Isa, S Robinson, ...
Nucleic acids research 42 (14), 9424-9435, 2014
Upoważnienia: UK Biotechnology and Biological Sciences Research Council
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
A Harrod, J Fulton, VTM Nguyen, M Periyasamy, L Ramos-Garcia, CF Lai, ...
Oncogene 36 (16), 2286-2296, 2017
Upoważnienia: Breast Cancer Now, UK, Cancer Research UK
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression
AE Frampton, L Castellano, T Colombo, E Giovannetti, J Krell, J Jacob, ...
Gastroenterology 146 (1), 268-277. e18, 2014
Upoważnienia: Cancer Research UK, UK Medical Research Council, Worldwide Cancer Research …
MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors
LR Jiao, AE Frampton, J Jacob, L Pellegrino, J Krell, G Giamas, N Tsim, ...
PloS one 7 (2), e32068, 2012
Upoważnienia: Cancer Research UK
Mammosphere formation assay from human breast cancer tissues and cell lines
Y Lombardo, A de Giorgio, CR Coombes, J Stebbing, L Castellano
Journal of visualized experiments: JoVE, 52671, 2015
Upoważnienia: Cancer Research UK, National Institute for Health Research, UK
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
AE Frampton, MM Prado, E López-Jiménez, AB Fajardo-Puerta, ...
Oncotarget 9 (27), 19006, 2018
Upoważnienia: National Institute for Health Research, UK
Visceral adipose tissue immune homeostasis is regulated by the crosstalk between adipocytes and dendritic cell subsets
CE Macdougall, EG Wood, J Loschko, V Scagliotti, FC Cassidy, ...
Cell metabolism 27 (3), 588-601. e4, 2018
Upoważnienia: British Heart Foundation, UK Medical Research Council
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer
G Giamas, A Filipović, J Jacob, W Messier, H Zhang, D Yang, W Zhang, ...
Nature medicine 17 (6), 715-719, 2011
Upoważnienia: US National Institutes of Health, Cancer Research UK
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy